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ABSTRACT 
Communicable Diseases are caused by various opportunistic pathogenic micro-organisms that pose a serious health threat to the health of 
human beings. The contagious diseases are spread by various pathogenic micro-organisms like bacteria, viruses, fungi, bacteria or Protozoa 
through various mediums like air, blood, feces or through other blood fluids etc. Malaria, Respiratory disorders, fever, Measles, athletes foot, 
rabies are some common examples of these diseases. Allopathic management of these diseases by synthetic drugs pose serious health threats 
like multi-drug resistance. Phytomedicines are considered the safest alternative sources of treatment to overcome the multi -drug resistance as 
the important phytoconstituents present in phytomedicines like alkaloids, flavonoids, phenols are known since time immemorial for their 
alleviation in chronic diseases like Cancer, Diabetes etc.  
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INTRODUCTION 
Communicable diseases are caused by various micro-
organisms. The most common causes of death in 
emergencies and disasters are acute respiratory infection, 
measles, malnutrition and, in endemic zones, malaria. Every 
year communicable diseases kill more than 14 million people 
throughout the world, predominantly in developing 
countries.1 At present, measles, pertussis and tetanus, 
diseases that affect children, are responsible for the majority 
of disability-adjusted life years lost. Measles accounts for 30 
million cases and 888 000 deaths worldwide annually. 
Synthetic drugs like antibiotics used for the managementt of 
these chronic diseases pose serious problems like Multi-drug 
resistance. Phytomedicines are considered the safest 
alternative sources of treatment to overcome the multi-drug 
resistance as  the important phytoconstituents present in 
phytomedicines like alkaloids, flavonoids, phenols are known 
since time immemorial for their alleviation in chronic 
diseases like Cancer, Diabetes etc. 
Antimicrobial substances of natural, semisynthetic or 
synthetic origin that kills or inhibits the growth of 
microorganisms but causes little or no damage to the host. 
Antimicrobial medicines can be grouped according to the 
microorganisms they act primarily against. For example, 
antibacterials (commonly known as antibiotics) are used 
against bacteria and antifungals are used against fungi. They 
can also be classed according to their function. 
Antimicrobials that kill microbes are called microbicidal; 
those that merely inhibit their growth are called 
microbiostatic. Disinfectants antimicrobial substances used 
on nonliving objects or outside the body.  
The history of antimicrobial begins with the observation of 
Pasteur and Joubert, who discovered that one type of 
bacteria could prevent the growth of another. They did not 
know at that time that the reason one bacterium failed to 
grow was that the other bacterium was producing an 
antibiotic. Technically antibiotics are only those substances 
that are produced by one microorganism that kill or prevent 
the growth of another microorganism. Of course, in today’s 
common usage, the term antibiotic is used to refer to almost 
any drug that attempts to rid your body of a bacterial 
infection. Antimicrobials include not just antibiotics, but 
synthetically formed compounds as well. 
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The discovery of antimicrobials like penicillin and 
tetracycline paved the way for better health for millions 
around the world. Before penicillin became a viable medical 
treatment in the early 1940s, no true cure for gonorrhea, 
strep throat and pneumonia existed. Patients with infected 
wounds often had a wounded limb removed or face death 
from infection. Now, most of these infections can be cured 
easily with a short course of antimicrobials. 
However with the development of antimicrobials, 
microorganisms have adapted and become resistant to 
previous antimicrobial agents. The old antimicrobials 
technology was based either on poisons or heavy metals, 
which may not have killed the microbe completely, allowing 
the microbe to survive, change and become resistant to the 
poisons and /or heavy metals. 
Antimicrobial nanotechnology is a recent addition to fight 
against disease causing organisms, replacing heavy metals 
and toxins and may someday be a viable alternative. 
Infections that are acquired during a hospital visit are called 
hospital acquired infections or nosocomial infections. 
Similarly when the infectious disease is picked up in the non 
hospital setting it is considered “community acquired.” 
There are mainly two classes of antimicrobial drugs. 
1. Those obtained from natural sources. 
 Beta lactam antibiotic (such as penicillins, 
Cephalosporins) 
 Protein synthesis inhibitors (such as aminoglycosides, 
macrolides, tetracycline, chloramphenicol 
polypeptides) 
2. Synthetic agents 
  Sulphonamides 
 Anti virals 
 Anti fungals 
  Anti cancer drugs 
 Anti malarials 
 Anti tuberculosis drugs 
 Antileprotics and Anti protozoals 
The potential for developing antimicrobials from higher 
plants appear rewarding as it will lead to the development of 
a phytomedicine to act against microbes; as a result, plants 
are one of the bedrocks for modern medicine to attain new 
principles1. Plant based antimicrobials represent a vast 
untapped source of medicine. Plant based antimicrobials 
have enormous therapeutic potential as they can serve the 
purpose without any side effects that are often associated with 
synthetic antimicrobials. Further continued exploration of 
plant derived antimicrobials is needed today2.  
Scientific experiments on the antimicrobial properties of 
plant components were first documented in the late 19th 
century.3 It is estimated that today, plant materials are 
present in, or have provided the models for 50% Western 
drugs.4 Many commercially proven drugs used in modern 
medicine were initially used in crude form in traditional or 
folk healing practices, or for other purposes that suggested 
potentially useful biological activity. The primary benefits of 
using plant derived medicines are that they are relatively 
safer than synthetic alternatives, offering profound 
therapeutic benefits and more affordable treatment. 
The medicinal plants around the world contain many 
compounds with antibacterial activity.5 Many efforts have 
been made to discover new antimicrobial compounds from 
various sources such as microorganisms, animals, and plants. 
Systematic screening of them may result in the discovery of 
novel effective antimicrobial compounds. The use of 
botanical medicines is generally on the rise in many parts of 
the world.6 The screening of plant extracts and plant 
products for antimicrobial activity has shown that plants 
represent a potential source of new anti-infective agents.7,8,9 
Numerous experiments have been carried out to screen 
natural products for antimicrobial property.10,11,12 
Considering the above, it can be stated that plants are 
valuable sources for new compounds and should receive 
special attention in research strategies to develop new 
antimicrobials urgently required in the near future.13,14  
CONCLUSION 
The current review provides a detailed and comprehensive 
detail on the emphasis of Phytomedicines in chronic diseases 
to overcome the serious problems posed by the synthetic 
antimicrobial agents. 
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